Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach

Omicron, a variant of concern (VOC) of SARS-CoV-2, emerged in South Africa in November 2021. Omicron has been continuously acquiring a series of new mutations, especially in the spike (S) protein that led to high infectivity and transmissibility. Peptides targeting the receptor-binding domain (RBD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Swati, Banavath, Hemanth Naick, Godara, Priya, Naik, Biswajit, Srivastava, Varshita, Prusty, Dhaneswar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342843/
https://www.ncbi.nlm.nih.gov/pubmed/35923684
http://dx.doi.org/10.1007/s13205-022-03258-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342843/
https://www.ncbi.nlm.nih.gov/pubmed/35923684
http://dx.doi.org/10.1007/s13205-022-03258-4

Ejemplares similares